Saturday 17 October 2026
Export MDLN’s income statement to Excel — free account
Medline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.7% and free cash flow grew 3.42%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
35.96
0.61
−1.67%
Follow MDLN
Medline Inc. (MDLN) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BAX Baxter International Inc. compare | n/m |
| SOLV Solventum Corporation compare | 10.4× |
| RMD ResMed Inc. compare | 22.8× |
| ISRG Intuitive Surgical, Inc. compare | 48.3× |
| WST West Pharmaceutical Services, Inc. compare | 48.7× |
| ALC Alcon compare | 50.5× |
| BDX Becton, Dickinson and Company compare | 57.8× |
| RGEN Repligen Corporation compare | 234× |
| MDLN Medline Inc. | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)